Pioneering Genome Editing Solution Unveiled by Mission Bio

The Tapestri® Genome Editing Solution has been introduced by Mission Bio, a biotechnology firm focused on single-cell multi-omic solutions for precision medicine.

This pioneering technology addresses a prevalent need in the development of enhanced treatment options, disease modeling, and functional genomics by meeting an urgent demand for quality evaluation of genome editing.

There are several uses for the Tapestri® Genome Editing Solution, primarily for studying disease in the lab, medicine development specialists, and genome engineers. The application enables gene-edited pharmaceuticals to be promptly analyzed, detecting target editing, changes in genetic sequencing, and allowing simultaneous editing of several targets just one cell.

The method also involves multi-omic assessment, which helps to identify which kinds of cell have undergone editing or even confirm a knockout by looking at whether there has been a loss of a protein.

The next Cell Therapy Analytical Development Summit, which takes place in Amsterdam from September 19–21, will feature a demonstration of the solution.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.